(Q34464661)

2 August 2017

1 reference

title

Therapy insight: Potential of statins for cancer chemoprevention and therapy (English)

1 reference

2 August 2017

Matthew S Katz

1

1 reference

2 August 2017

publication date

1 February 2005

1 reference

Nature Clinical Practice Oncology

2 August 2017

published in

1 reference

2 August 2017

volume

2

1 reference

2 August 2017

issue

2

1 reference

2 August 2017

page(s)

82-89

1 reference

Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators.

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0097

Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0097

Case-control study of non-Hodgkin's lymphoma among women and heterosexual men in the San Francisco Bay Area, California

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0097

Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0097

7 January 2021

Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TEXCAPS): additional perspectives on tolerability of long-term treatment with lovastatin

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0097

7 January 2021

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0097

7 January 2021

Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-up

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0097

7 January 2021

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0097

7 January 2021

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0097

7 January 2021

Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S).

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0097

7 January 2021

Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0097

7 January 2021

Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0097

7 January 2021

Do statins cause cancer? A meta-analysis of large randomized clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0097

7 January 2021

Safety and tolerability of pravastatin in long-term clinical trials: prospective Pravastatin Pooling (PPP) Project

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0097

7 January 2021

The association between 3-hydroxy-3-methylglutaryl conenzyme A inhibitor use and breast carcinoma risk among postmenopausal women: a case-control study.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0097

7 January 2021

The Risk of Cancer in Users of Statins

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0097

7 January 2021

Regulation of the mevalonate pathway

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0097

7 January 2021

Pleiotropic effects of statins

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0097

7 January 2021

HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0097

7 January 2021

The statins: multifunctional antithrombotic and antineoplastic drugs

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0097

7 January 2021

Statins have biphasic effects on angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0097

7 January 2021

Double-edged role of statins in angiogenesis signaling

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0097

7 January 2021

Statins augment collateral growth in response to ischemia but they do not promote cancer and atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0097

7 January 2021

Carcinogenicity of lipid-lowering drugs

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0097

7 January 2021

Cancer among men on cholesterol-lowering diets: Experience from five clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0097

7 January 2021

Statin use and the risk of breast and prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0097

7 January 2021

Human plasma lipoproteins. I.In normal women and in women with advanced carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0097

7 January 2021

Low cholesterol and cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0097

7 January 2021

Statin use and cancer risk in the General Practice Research Database

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0097

7 January 2021

Time trends in serum cholesterol before cancer death

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0097

7 January 2021

Inflammation in atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0097

7 January 2021

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0097

7 January 2021

Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0097

7 January 2021

Inflammation and cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0097

7 January 2021

Lipid-Lowering Medication and Risk of Cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0097

7 January 2021

3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and the risk of cancer: a nested case-control study

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0097

7 January 2021

Statin use and the risk of breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0097

7 January 2021

Lipid-Lowering Drug Use and Breast Cancer in Older Women: A Prospective Study

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0097

7 January 2021

Prior medical conditions and medication use and risk of non-Hodgkin lymphoma in Connecticut United States women

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0097

7 January 2021

Population-based study of non-Hodgkin lymphoma, histology, and medical history among human immunodeficiency virus-negative participants in San Francisco

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0097

7 January 2021

Phase II study of high-dose lovastatin in patients with advanced gastric adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0097

7 January 2021

Security and maximal tolerated doses of fluvastatin in pediatric cancer patients.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0097

7 January 2021

Association of statin use with a pathologic complete response to neoadjuvant chemoradiation for rectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0097

7 January 2021

Effect of pravastatin on survival in patients with advanced hepatocellular carcinoma. A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0097

7 January 2021

A phase I-II trial of lovastatin for anaplastic astrocytoma and glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0097

7 January 2021

Barriers to drug delivery in solid tumors

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0097

7 January 2021

Angiogenesis in cancer, vascular, rheumatoid and other disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0097

7 January 2021

Prior statin therapy is associated with a decreased rate of severe sepsis

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0097

7 January 2021

Statins inhibit HIV-1 infection by down-regulating Rho activity.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0097

7 January 2021

Prevention of stroke and dementia with statins: Effects beyond lipid lowering

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0097

7 January 2021

Oral simvastatin treatment in relapsing-remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0097

7 January 2021

Identifiers

DOI

10.1038/NCPONC0097

1 reference

2 August 2017

1 reference